WO2025083565 - PHENOTYPE AND GENOTYPE TARGET-BASED SMALL MOLECULE INHIBITORS IN CANCERS
National phase entry is expected:
Publication Number
WO/2025/083565
Publication Date
24.04.2025
International Application No.
PCT/IB2024/060125
International Filing Date
16.10.2024
Title **
[English]
PHENOTYPE AND GENOTYPE TARGET-BASED SMALL MOLECULE INHIBITORS IN CANCERS
[French]
INHIBITEURS À PETITES MOLÉCULES À BASE DE CIBLE DE PHÉNOTYPE ET DE GÉNOTYPE DANS DES CANCERS
Applicants **
PILLAI UNIVERSAL LLC
PILLAI, Dr. BASKARAN
M.G., Dinesh
Inventors
PILLAI, Dr. BASKARAN
M.G., Dinesh
Priority Data
202341028322
18.10.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| * | |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1948 | |
| EPO | Filing, Examination, Granting | 11576 | |
| Japan | Filing, Examination, Granting | 1961 | |
| South Korea | Filing, Examination, Granting | 1638 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,863
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention discloses a Phenotype and genotype target-based small molecule inhibitors in cancers The novel anti-cancer molecules comprises of structures in accordance with Formula (1). Formula (1) or any derivative thereof, pharmaceutically acceptable salt thereof, or combination thereof in which: R is oxo group or imine group A is hydroxyl group or amino group B is hydroxyl group or Hydrogen[French]
La présente invention concerne des inhibiteurs à petites molécules à base de cible de phénotype et de génotype dans des cancers. Les nouvelles molécules anticancéreuses comprenant des structures selon la formule (1). Formule (1) ou un dérivé quelconque de celles-ci, un sel pharmaceutiquement acceptable de celles-ci, ou une combinaison de ceux-ci. R représentant un groupe oxo ou un groupe imine, A représentant un groupe hydroxyle ou un groupe amino, B représentant un groupe hydroxyle ou un atome d'hydrogène